Proteus Interim Data Shows 30x More Alignments Than Platinum Pro
QSI sits 20% above its 52-week low of $0.69.
Summary
Quantum-Si presented interim Proteus data at World HUPO 2026 showing a significant performance leap over its current Platinum Pro platform. Proteus delivered 30x more alignments, a 4.8x lower false discovery rate, and detected all 24 proteins in a panel where Platinum Pro averaged 20.3. The company projects a full four-chamber Proteus run could yield 60x more alignments than Platinum Pro. This follows the August 13 announcement delaying Proteus launch to Q2 2027 and a 20% workforce cut, so these results are a critical validation of the platform's potential. The stock trades at $0.83 with a $174M market cap and faces Nasdaq delisting risk, making this data a key catalyst for investor confidence. The presentation is scheduled for September 29 at the HUPO Congress in Singapore.
Updates
· SEC 8-K — The 8-K attaches the World HUPO 2026 presentation and press release, including interim Proteus data showing 30x more alignments, 4.8x lower FDR, and detection of all 24 proteins.
At the time of this announcement, QSI was trading at $0.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $174M. The 52-week trading range was $0.69 to $3.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.